Article: Abbott Discontinues Essential Narcolepsy Medication As Public Citizen's Health Research Group Calls for Complete Ban.

Byline: Narcolepsy Network

NEW YORK, April 27 (AScribe Newswire) -- Narcolepsy Network Inc., announced to its members today that Abbott Laboratories will cease production of Cylert, a medication used by an estimated 10,000 Americans afflicted with the sleep disorders of narcolepsy and idiopathic hypersomnia. In an untreated state, both of these disorders are characterized by excessive sleepiness and sleep attacks during the day. At the same time, Public Citizen's Health Research Group, on behalf of individuals with ADHD, has petitioned the FDA to ban Cylert and its generic equivalent, Pemoline, due to risks associated with this medication.

In 1975, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!